MM

Mrinmoy Mitra

Active Director Director DIN 08989270
DIN 08989270 First appointment Dec 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Mrinmoy Mitra

Data last updated:

Mrinmoy Mitra is a Director at Artim's Pharma Private Limited (since 2020). The company operates in Trading. Artim's Pharma Private Limited reported revenue of ₹37.6 Lakh (FY 2024).

DIN 08989270
Primary Designation Director
Industry Trading
First Appointment 09 Dec 2020
Oldest Company Age 5 yrs
Largest company Artim's Pharma Private Limited · ₹37.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Artim's Pharma Private Limited U51909WB2020PTC241831
Director09 Dec 20202020₹37.6 Lakh (FY 2024)Active

Board colleagues of Mrinmoy Mitra

NameDINCompanyDesignation
Putul Mitra08989271Artim's Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Artim's Pharma Private Limited
Premium access

Shareholding and investment profile for Mrinmoy Mitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mrinmoy Mitra

Mrinmoy Mitra currently holds 1 directorship: Artim's Pharma Private Limited (Director, since 09 Dec 2020, revenue ₹37.6 Lakh (FY 2024)).

Mrinmoy Mitra was first appointed on 09 Dec 2020 as Director at Artim's Pharma Private Limited.

The current boards of Mrinmoy Mitra's companies include Putul Mitra (Artim's Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available